Figure 2From: Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study Maximum change in sum of longest diameters of target NET lesions (n = 27) . Each bar represents data for a single patient.Back to article page
